Industry »Diagnostics & Research« (36)
Filter by Size, Price, EPS, Revenue, Debt, Returns and many other Dividend and Fundamental Data.
Results
36 matches
| SYMBOL | INDUSTRY | MKT CAP | VRT | SIGNAL | SAFETY | RS | DIV. YIELD |
|---|---|---|---|---|---|---|---|
| TMO NYSE Thermo Fisher Scientific |
Life Sciences Tools
Laboratory Instruments, Reagents |
167B | 49 | -0.48 | 79 | 17 | 0.4% |
| DHR NYSE Danaher |
Health Care Equipment
Bioprocessing Equipment |
121B | 40 | -0.71 | 75 | 11 | 0.7% |
| IDXX NASDAQ IDEXX Laboratories |
Health Care Equipment
Diagnostic Analyzers, Test Kits |
44.1B | 63 | 0.11 | 86 | 15 | - |
| WAT NYSE Waters |
Life Sciences Tools
Liquid Chromatography, Mass |
33.6B | 46 | -0.27 | 46 | 30 | - |
| A NYSE Agilent Technologies |
Life Sciences Tools
Chromatography, Mass Spectrometry |
32.5B | 41 | -1.00 | 71 | 21 | 0.8% |
| NTRA NASDAQ Natera |
Biotechnology
Prenatal Testing, Oncology |
29.1B | 43 | -0.54 | 26 | 41 | - |
| IQV NYSE IQVIA Holdings |
Life Sciences Tools
Clinical Research, Healthcare |
28.2B | 42 | -0.33 | 63 | 19 | - |
| MTD NYSE Mettler-Toledo International |
Life Sciences Tools
Precision Balances, Analytical |
22.1B | 50 | -0.43 | 74 | 11 | - |
| ILMN NASDAQ Illumina |
Life Sciences Tools
DNA Sequencers, Reagents |
21.5B | 69 | 0.40 | 72 | 80 | - |
| DGX NYSE Quest Diagnostics |
Health Care Providers
Clinical Testing, Anatomic |
21.5B | 68 | -0.12 | 91 | 34 | 1.8% |
| LH NYSE Laboratory of America |
Health Care Providers
Diagnostic Testing, Clinical |
21.1B | 53 | -0.40 | 73 | 22 | 1.1% |
| GH NASDAQ Guardant Health |
Health Care Providers
Liquid Biopsy, Cancer Screening |
15.8B | 46 | 0.54 | 33 | 92 | - |
| ERF PA Eurofins Scientific SE |
Biotechnology
Laboratory Testing, Clinical |
12.7B | 56 | -0.83 | 83 | 29 | 1.2% |
| MEDP NASDAQ Medpace Holdings |
Life Sciences Tools
Clinical Trials, Laboratory |
12.3B | 61 | 0.08 | 67 | 29 | - |
| RVTY NYSE Revvity |
Life Sciences Tools
Diagnostic Kits, Laboratory |
10.8B | 49 | -0.49 | 77 | 29 | 0.3% |
| BIM PA Biomerieux |
Biotechnology
Diagnostic Tests, Microbiology |
10.1B | 49 | -0.76 | 84 | 3 | 0.7% |
| ICLR NASDAQ ICON |
Life Sciences Tools
Clinical Trials, Laboratory |
9.08B | 30 | -0.30 | 67 | 14 | - |
| CRL NYSE Charles River Laboratories |
Life Sciences Tools
Research Models, Drug Discovery |
7.72B | 50 | 0.02 | 69 | 81 | - |
| QIA XETRA QIAGEN |
Biotechnology
Sample Technologies, Diagnostic |
7.27B | 34 | -0.89 | 78 | 6 | 5.3% |
| QGEN NYSE Qiagen |
Life Sciences Tools
Sample Preparation, Molecular |
7.25B | 38 | -0.57 | 86 | 7 | 5.2% |
| SHC NASDAQ Sotera Health |
Life Sciences Tools
Sterilization Services, Lab |
4.47B | 51 | -0.20 | 71 | 36 | - |
| RDNT NASDAQ RadNet |
Health Care Providers
Diagnostic Imaging, Medical |
4.28B | 22 | -0.87 | 56 | 8 | - |
| BLLN NASDAQ BillionToOne, Common Stock |
Health Care Equipment
Prenatal Screening, Liquid Biopsy |
3.96B | 45 | -0.97 | 73 | 22 | - |
| DIA MI DiaSorin S.p.A. |
Biotechnology
Immunodiagnostics, Molecular |
3.74B | 37 | -0.23 | 76 | 17 | 3.1% |
| VCYT NASDAQ Veracyte |
Biotechnology
Genomic Tests, Cancer Diagnostics |
3.61B | 59 | 0.08 | 37 | 76 | - |
| TWST NASDAQ Twist Bioscience |
Biotechnology
Synthetic DNA, Oligo Pools, NGS |
3.34B | 41 | 0.21 | 20 | 94 | - |
| GRAL NASDAQ GRAIL |
Biotechnology
Cancer Screening, Diagnostic Aids |
2.91B | 38 | -0.08 | 38 | 80 | - |
| ADPT NASDAQ Adaptive Biotechnologies |
Life Sciences Tools
Immunosequencing, Diagnostic |
2.22B | 45 | -0.42 | 36 | 34 | - |
| NEO NASDAQ NeoGenomics |
Health Care Providers
Cancer Diagnostics, Genetic |
1.16B | 29 | -0.06 | 39 | 41 | - |
| CDNA NASDAQ CareDx |
Biotechnology
Transplant Diagnostics, Genetic |
1.12B | 54 | 0.08 | 38 | 77 | - |
| OPK NASDAQ Opko Health |
Biotechnology
Diagnostic Tests, Hormones |
959M | 18 | -0.53 | 24 | 30 | - |
| PSNL NASDAQ Personalis |
Life Sciences Tools
Genomic Tests, Liquid Biopsy |
887M | 24 | -0.17 | 29 | 79 | - |
| CSTL NASDAQ Castle Biosciences |
Biotechnology
Molecular Diagnostics, Genetic |
608M | 36 | -0.84 | 46 | 8 | - |
| FLGT NASDAQ Fulgent Genetics |
Health Care Providers
Genetic Testing, Molecular |
486M | 24 | -0.85 | 81 | 6 | - |
| MYGN NASDAQ Myriad Genetics |
Biotechnology
Genetic Tests, Cancer Diagnostics |
361M | 13 | -0.59 | 27 | 6 | - |
| PRE NASDAQ Prenetics Global |
Insurance
Genetic Testing, Wellness |
285M | 41 | 0.19 | 32 | 88 | - |
Technical
Structure
Fundamental
Topics in Industry »Diagnostics & Research« (36)
- Clinical Trials
- Molecular Diagnostics
- Genetic Testing
- Reagents
- Laboratory Services
- Liquid Biopsy
- Cancer Screening
- Diagnostic Tests
- Cancer Diagnostics
- Laboratory Instruments
- Diagnostic Kits
- Analytical Instruments
- Mass Spectrometry
- PCR Instruments
- Bioinformatics Software
- Molecular Assays
- Prenatal Screening
- Genomic Tests
- Research Services
- Genetic Tests